Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J CURIEL

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
The Journal of Infectious Diseases|April 1, 1995
Cross-reactivity of human Toxoplasma-specific T cells: implications for development of a potential immunotherapeutic or vaccineM B Purner, E C Krug, P Nash, et al.
Expert Opinion on Drug Delivery|December 22, 2007
Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapyMichael J Brumlik, Benjamin J Daniel, Reinhard Waehler, et al.
Current Treatment Options in Oncology|February 5, 2015
Immunotherapy for ovarian cancerJustin M Drerup, Yang Liu, Alvaro S Padron, et al.
Cell Systems|October 8, 2021
Alignment of single-cell trajectories by tuMap enables high-resolution quantitative comparison of cancer samplesAyelet Alpert, Ornit Nahman, Elina Starosvetsky, et al.
Human Gene Therapy|December 1, 1993
Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphtheria toxin A chain geneT J Curiel, D R Cook, Y Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 20, 1998
Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosisP B Nash, M B Purner, R P Leon, et al.
Human Gene Therapy|November 1, 1995
HIV-regulated diphtheria toxin A chain gene confers long-term protection against HIV type 1 infection in the human promonocytic cell line U937M M Dinges, D R Cook, J King, et al.
Biotechniques|November 1, 1995
Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cellsG S Harrison, Y Wang, J Tomczak, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammationBogang Wu, Huai-Chin Chiang, Xiujie Sun, et al.
Free Radical Biology & Medicine|January 1, 1992
Progressive increases in serum catalase activity in advancing human immunodeficiency virus infectionJ A Leff, M A Oppegard, T J Curiel, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Infectious Diseases|April 1, 1995
Cross-reactivity of human Toxoplasma-specific T cells: implications for development of a potential immunotherapeutic or vaccineM B Purner, E C Krug, P Nash, et al.
Expert Opinion on Drug Delivery|December 22, 2007
Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapyMichael J Brumlik, Benjamin J Daniel, Reinhard Waehler, et al.
Current Treatment Options in Oncology|February 5, 2015
Immunotherapy for ovarian cancerJustin M Drerup, Yang Liu, Alvaro S Padron, et al.
Cell Systems|October 8, 2021
Alignment of single-cell trajectories by tuMap enables high-resolution quantitative comparison of cancer samplesAyelet Alpert, Ornit Nahman, Elina Starosvetsky, et al.
Human Gene Therapy|December 1, 1993
Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphtheria toxin A chain geneT J Curiel, D R Cook, Y Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 20, 1998
Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosisP B Nash, M B Purner, R P Leon, et al.
Human Gene Therapy|November 1, 1995
HIV-regulated diphtheria toxin A chain gene confers long-term protection against HIV type 1 infection in the human promonocytic cell line U937M M Dinges, D R Cook, J King, et al.
Biotechniques|November 1, 1995
Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cellsG S Harrison, Y Wang, J Tomczak, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammationBogang Wu, Huai-Chin Chiang, Xiujie Sun, et al.
Free Radical Biology & Medicine|January 1, 1992
Progressive increases in serum catalase activity in advancing human immunodeficiency virus infectionJ A Leff, M A Oppegard, T J Curiel, et al.
Pageof 15